nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—PDE5A—clitoris—vaginal cancer	0.794	0.794	CbGeAlD
Avanafil—PDE5A—epithelium—vaginal cancer	0.0395	0.0395	CbGeAlD
Avanafil—PDE5A—uterine cervix—vaginal cancer	0.0391	0.0391	CbGeAlD
Avanafil—PDE5A—urethra—vaginal cancer	0.036	0.036	CbGeAlD
Avanafil—PDE5A—female reproductive system—vaginal cancer	0.0293	0.0293	CbGeAlD
Avanafil—PDE5A—female gonad—vaginal cancer	0.0267	0.0267	CbGeAlD
Avanafil—PDE5A—vagina—vaginal cancer	0.0265	0.0265	CbGeAlD
Avanafil—CYP3A4—female reproductive system—vaginal cancer	0.00914	0.00914	CbGeAlD
